---
title: "Regentis Biomaterials (RGNT.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RGNT.US/norm.md"
symbol: "RGNT.US"
name: "Regentis Biomaterials"
parent: "https://longbridge.com/zh-CN/quote/RGNT.US.md"
datetime: "2026-06-13T22:06:03.579Z"
locales:
  - [en](https://longbridge.com/en/quote/RGNT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGNT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGNT.US/norm.md)
---

# Regentis Biomaterials (RGNT.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -6.95 | -6.95 | -0.5888 | -0.5888 | -0.4377 |
| ROE | -569.18% | 136.41% | 0.86% | 0.89% | 0.69% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -6.75M | -6.75M | -95500.00 | -95500.00 | -71000.00 |
| 营业利润 | -3.26M | -3.26M | -219500.00 | -219500.00 | -470500.00 |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 7.62M | 7.62M | 475000.00 | 475000.00 | 482000.00 |
| 权益乘数 | 1.61 | 1.61 | -0.0514 | -0.0514 | -0.0803 |
| 每股净资产 | 0.9159 | 0.9159 | -273.32 | -273.32 | -253.42 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 7.38M | 7.38M | 189000.00 | 189000.00 | 229000.00 |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -6.18M | -6.18M | 7.97M | 7.97M | 4.72M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -517500.00 | -517500.00 | -170000.00 | -170000.00 | -323500.00 |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 4.11M | 4.11M | 150000.00 | 150000.00 | 350000.00 |
| 自由现金流 | 1.48M | 1.66M | -137188.00 | -168188.00 | -294063.00 |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | 0.0000 | 0.0000 | 150000.00 | 150000.00 | 350000.00 |
| 资本支出 | - | - | - | - | - |